October Pharma S.A.E

E£189.92As of Sun 8 Nov 2026, 12:00 UTC
EGX:OCPHHealthcare
Country Egypt
PE (Fwd) •••
TSR 9Y CAGR 35.53%
Div yield 0.66%
ROE 28.29%
Pharmaceutical Preparations
Beta (5Y) 0.79
PE TTM 27.61
TSR TTM 80.77%
Mkt cap E£4.558B
ROIC 30.13%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£231
21.86%
(66.65%)
Hold 9|11|12|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
2.23
2.17
2.11
2.25
6.80%
8.17%
6.25%
9.96%
RevenueE£M
234.5
234.1
247.7
247.8
7.71%
5.04%
11.43%
7.56%
Peers (US$83.40M)
Cap (US$)
PE
124.0M
14.37x
58.02M
13.45x
86.44M
26.89x
Capital
TTM
5Y
10Y
Leveragex
1.400
0.145
0.131
EBIT/Intx
0.106
0.167
0.141
Own earn%
(9.14)
85.95
87.78
Sh yield%
25.86
25.33
25.28
Owners
Insiders/Inst%
0.23
53.52
Short interest%
1.91
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
32–34
$1 testx
0.7
Incr. ROIC%
7